Labixiaoxin Snacks Group Limited reported no movement in either authorised or issued share capital for the month ended 31 May 2026, according to its latest monthly return filed with Hong Kong Exchanges and Clearing.

Authorised Capital • Authorised share capital stood unchanged at 500.00 million ordinary shares with a par value of USD 0.001 each, equivalent to USD 0.50 million.

Issued Shares and Treasury Position • Issued shares (excluding treasury shares): 239.25 million, flat versus the previous month. • Treasury shares: none; no shares were repurchased, cancelled, or re-allotted during the period. • Total issued share count therefore remained 239.25 million.

Public Float Confirmation • The company affirmed compliance with the Main Board’s minimum public float requirement of 25% of issued shares.

Equity Incentive Capacity • Under the Share Option Scheme adopted on 23 June 2021, Labixiaoxin can issue or transfer up to 13.29 million additional shares, although no options were outstanding or granted during May 2026, and no shares were issued under the scheme.

Funding Activity • The filing discloses no proceeds raised from option exercises or other equity-linked instruments during the month.

Overall, Labixiaoxin’s capital structure and share count remained stable in May, with sufficient public float and unused headroom under its existing share option scheme.